Insulin resistance: Definition and consequences

Experimental and Clinical Endocrinology and Diabetes

Volumn 109, Issue SUPPL. 2, 2001, Pages

  Lebovitz, H E ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Fetal malnutrition; Free fatty acids; Insulin action; Syndrome X; Visceral obesity

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; INSULIN; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PIOGLITAZONE; ROSIGLITAZONE;

ARTICLE; CORONARY ARTERY DISEASE; DRUG EFFECT; FETUS DISEASE; GENETIC DISORDER; GROWTH REGULATION; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN TREATMENT; MALNUTRITION; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SYNDROME X;

CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; OBESITY; PLACENTAL INSUFFICIENCY; PREGNANCY; TERMINOLOGY;

EID: 0034973768     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-18576     Document Type: Article

References (62)

1. Relationship of generalized and regional adiposity to insulin sensitivity in men
2. Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes
3. Does intra-abdominal adipose tissue in black men determine whether NIDDM is insulin-resistant or insulin sensitive?
4. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM
5. Body composition, visceral fat, leptin and insulin resistance in Asian men
6. Insulin sensitive and insulin resistant variants in NIDDM
7. Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects
8. Weight in infancy and death from ischaemic heart disease
9. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): Relation to reduced fetal growth
10. Insulin resistance syndrome in 8-year old Indian children
11. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
12. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes
13. Serum lipoproreins in African Americans and whites with non-insulin dependent diabetes in the US population
14. Impaired activation of phosphoinositide 3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudoacromegaly
15. Hyperinsulinemia as an independent risk factor for ischemic heart disease
16. Effects of free fatty acids on glucose transport and IRS-1 associated phosphatidylinositol-3-kinase activity
17. Insulin resistance and the polycystic ovary syndrome: Mechanisms and implications for pathogenesis
18. High blood pressure and insulin resistance: Influence of ethnic background
19. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: The Rancho Bernardo study, 1984-1991
20. Insulin-mediated pseudoacromegaly: Clinical and biochemical characterization of a syndrome of severe insulin resistance
21. Syndromes of insulin resistance and mutant insulin
22. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: The Paris prospective study, 15-year follow-up
23. Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells
24. Effects of weight loss on regional fat distribution and insulin sensitivity in obese
25. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat
26. Fetal and infant growth and impaired glucose tolerance at age 64 years
27. Diabetes mellitus. A differerentiation into insulin-sensitive and insulin-insensitive types
28. Tumor necrosis factor α: A key component of the obesity-diabetes link
29. Insulin sensitivity and atherosclerosis
30. Cardiovascular risk continuum: Implications of insulin resistance and diabetes
31. Efficacy and metabolic effects of metformin and troglitazone in type 2 diabetes mellitus
32. Normal insulin-dependent activation of Akt/protein kinase B with diminished activation of phosphoinositide-3-kinase, in muscle in type 2 diabetes
33. Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow-up of participants in the population study of women in Gothenburg, Sweden
34. The metabolic syndrome
35. Rosiglitazone monotherapy is effective in patients with type 2 diabetes
36. Seven year changes in body fat and visceral adipose tissue in women. Associations with indexes of plasma glucose-insulin homeostasis
37. Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus
38. Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin-dependent diabetes mellitus
39. Effects of infant birthweight and maternal body mass index in pregnancy on components of the insulin resistance syndrome in China
40. Hyperinsulinemia: A link between hypertension, obesity and glucose intolerance
41. The perils of portliness. Causes and consequences of visceral adiposity
42. The influence of body fat distribution on the incidence of diabetes mellitus
43. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes: Studies with a selective inhibitor wortmannin
44. Serum insulin and incident coronary heart disease in middle-aged British men
45. Elevated plasma cortisol concentrations: A link between low birth weight and the insulin resistance syndrome
46. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland
47. Role of insulin resistance in human disease
48. Metabolic and vascular effects of the thiazolidinedione troglitazone
49. Increasing incidence of type 2 diabetes in the third millennium. Is abdominal fat the central issue?
50. Predicting diabetes. Moving beyond impaired glucose tolerance
51. The insulin resistance syndrome
52. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII mortality and selected nonfatal events with insulin treatment
53. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
54. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
55. Ethnicity and cardiovascular disease (UKPDS 32)
56. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
57. The assessment of insulin action in vivo
58. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations
59. Hyperinsulinaemia is not a major coronary risk factor in elderly men
60. The molecular basis of insulin action
61. The PPARs: From orphan receptors to drug discovery
62. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients